Keisuke Uehara
Papers
3
Total Citations
105
H-Index
3
About
Dr. Keisuke Uehara is a leading colorectal surgeon whose work is reshaping the surgical management of rectal cancer, with a particular focus on minimally invasive techniques and oncologic precision. His research centers on comparing and optimizing surgical approaches—specifically robot-assisted, conventional laparoscopic, and transanal total mesorectal excision (taTME)—to improve patient outcomes. Dr. Uehara’s most impactful contribution is a landmark 2021 study (78 citations) using the Japanese National Clinical Database, which demonstrated the peri-operative benefits of robot-assisted low anterior resection (RALAR) over conventional laparoscopy through a rigorous propensity-matched analysis. He further advanced the field by leading the PRODUCT trial, a prospective multicenter study that validated the use of circumferential resection margin (CRM) as a quality metric for laparoscopic surgery in locally advanced rectal cancer. Dr. Uehara is also a key voice on the expanding role of taTME, highlighting its utility not only for distal rectal tumors but also for complex extended pelvic surgeries. With over 100 cumulative citations, his work provides crucial, population-level evidence that directly informs surgical decision-making and sets new standards for rectal cancer care in Japan and globally.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3